Brandywine Global Investment Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.9M | Buy |
428,579
+4,297
| +1% | +$300K | 0.21% | 126 |
|
|
2025
Q1 | $31.2M | Sell |
424,282
-4,159
| -1% | -$306K | 0.22% | 120 |
|
|
2024
Q4 | $28.1M | Buy |
+428,441
| New | +$28.1M | 0.2% | 126 |
|
|
2024
Q1 | – | Sell |
-378,847
| Closed | -$25.5M | – | 705 |
|
|
2023
Q4 | $25.5M | Buy |
378,847
+28,597
| +8% | +$1.93M | 0.21% | 120 |
|
|
2023
Q3 | $23.7M | Sell |
350,250
-110,273
| -24% | -$7.47M | 0.21% | 125 |
|
|
2023
Q2 | $33M | Sell |
460,523
-13,788
| -3% | -$987K | 0.27% | 101 |
|
|
2023
Q1 | $32.9M | Sell |
474,311
-22,768
| -5% | -$1.58M | 0.27% | 108 |
|
|
2022
Q4 | $33.7M | Sell |
497,079
-26,200
| -5% | -$1.78M | 0.26% | 109 |
|
|
2022
Q3 | $28.7M | Sell |
523,279
-8,586
| -2% | -$471K | 0.27% | 104 |
|
|
2022
Q2 | $35.1M | Sell |
531,865
-32,361
| -6% | -$2.14M | 0.31% | 102 |
|
|
2022
Q1 | $37.4M | Sell |
564,226
-17,523
| -3% | -$1.16M | 0.27% | 106 |
|
|
2021
Q4 | $33.9M | Sell |
581,749
-330,524
| -36% | -$19.3M | 0.24% | 116 |
|
|
2021
Q3 | $54.8M | Buy |
912,273
+439,732
| +93% | +$26.4M | 0.41% | 63 |
|
|
2021
Q2 | $28.3M | Buy |
472,541
+47,018
| +11% | +$2.82M | 0.21% | 126 |
|
|
2021
Q1 | $21.2M | Buy |
425,523
+158,759
| +60% | +$7.89M | 0.16% | 159 |
|
|
2020
Q4 | $13.3M | Sell |
266,764
-41,100
| -13% | -$2.05M | 0.11% | 198 |
|
|
2020
Q3 | $16.9M | Sell |
307,864
-5,000
| -2% | -$274K | 0.17% | 140 |
|
|
2020
Q2 | $16.5M | Sell |
312,864
-156,350
| -33% | -$8.27M | 0.17% | 133 |
|
|
2020
Q1 | $21M | Sell |
469,214
-495,250
| -51% | -$22.1M | 0.25% | 93 |
|
|
2019
Q4 | $48.6M | Sell |
964,464
-32,400
| -3% | -$1.63M | 0.34% | 72 |
|
|
2019
Q3 | $44.4M | Sell |
996,864
-42,900
| -4% | -$1.91M | 0.33% | 74 |
|
|
2019
Q2 | $42.9M | Buy |
+1,039,764
| New | +$42.9M | 0.3% | 80 |
|